Evidence map›Paper›PMID 41647684›Full record

ArticleInternational journal of public health2026

Eligibility for Lung Cancer Screening in Switzerland: A Comparative Analysis of Three Data Sources From Lausanne and the Canton of Vaud.

Louis Gros, Cynthia Schneider, May-Lucie Meyer, Julie Korber, Yves Henchoz, Julien Vaucher, Pedro Marques-Vidal, Kevin Ten Haaf, Chiara Pozzessere, Cédric Bongard and 3 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Louis GrosDepartment of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Cynthia SchneiderCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
May-Lucie MeyerDepartment of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Julie KorberCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Yves HenchozCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Julien VaucherDepartment of Medicine and Specialties, Internal Medicine, Fribourg Hospital and University of Fribourg, Fribourg, Switzerland.
Pedro Marques-VidalDepartment of Medicine, Internal Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.
Kevin Ten HaafDepartment of Public Health, Erasmus MC-University Medical Center Rotterdam, Rotterdam, Netherlands.
Chiara PozzessereDepartment of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Cédric BongardDivision of Pulmonology, Department of Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Christophe Von GarnierDivision of Pulmonology, Department of Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Jean-Luc BulliardCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Kevin SelbyCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to estimate the proportion of individuals potentially eligible for lung cancer screening in Lausanne, canton of Vaud, Switzerland, and its associations with key sociodemographic and health-related covariates. Methods: We analyzed self-reported, cross-sectional data from three sources: Lausanne cohort 65+ (2014; Results: Eligibility was 18.2% in the Lc65+ cohort, 16.0% in CoLaus, and 14.4% in the Swiss Health Survey. Among eligible individuals, the prevalence of current smoking was 58.7% in Lc65+, 60.1% in the Swiss Health Survey, and 64.9% in CoLaus. Eligible participants tended to have a higher burden of comorbidities and social vulnerabilities, including cardiovascular disease, metabolic syndrome, depression, and lower education or income; statistically significant differences varied by dataset. Conclusion: In this Swiss population, about one in six adults met lung cancer screening criteria. Findings highlight the need for combining early detection with tobacco cessation, health promotion, and equitable access to care.

Indexed as

Early Detection of CancerEligibility DeterminationLung NeoplasmsAgedCross-Sectional StudiesFemaleHealth SurveysHumansMaleMiddle AgedSocioeconomic FactorsSwitzerlandhealth disparitieslung cancerscreening eligibilitysmoking cessationSwitzerland

Identifiers

PMID41647684
PMCPMC12867931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.